# When Your 75-Year-Old Patient Has Better Sleep but Insurance Says No > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/insurance-coverage-gaps-seniors-cannabis-care/ > **Published:** 2026-03-20T17:40:25-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T15:54:27-04:00 > **Clinical Summary:** Explore insurance coverage gaps seniors face in cannabis care, impacting sleep improvement and polypharmacy reduction in geriatric patients. --- CED Clinical Relevance  #82High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. 💡 Cannabis Education  |  CED Clinic Senior CareInsurance CoveragePolypharmacySleep Medicine[Healthcare Policy](https://cedclinic.com/cannabis-legalization-in-canada-new-opportunities/) Format Reaction meme Audience Clinicians and caregivers Primary Topic Senior cannabis care Why This Matters Insurance coverage gaps force clinicians to choose between optimal patient outcomes and accessible care, particularly problematic for seniors who often see dramatic improvements in sleep quality and reduced polypharmacy with [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). This policy-practice disconnect undermines evidence-based geriatric care when patients achieve measurable clinical benefits but face financial barriers to continued treatment. Clinical Summary [Cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) often produces remarkable outcomes in older adults, including improved sleep architecture, reduced benzodiazepine dependence, and decreased overall medication burden. However, insurance non-coverage creates a two-tiered system where clinical efficacy doesn’t translate to accessible care. This forces many seniors to choose between proven [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/) and financial sustainability, often leading to discontinuation of effective treatment and return to less optimal pharmaceutical regimens with higher side effect profiles. Dr. Caplan’s Take “I’ve watched too many 75-year-olds achieve their best sleep in decades and successfully taper off three sleep medications, only to stop cannabis treatment because Medicare won’t cover it. The irony is profound — insurance will pay for the polypharmacy that wasn’t working but not the single intervention that restored function.” Clinical Perspective 🧠 Clinicians should document comprehensive outcomes including sleep quality scores, medication reductions, and functional improvements to build the evidence base for future coverage decisions. When discussing cannabis with older patients, address insurance limitations upfront and explore patient assistance programs or lower-cost product options to maintain therapeutic continuity. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20When%20your%2075-year-old%20patient%20has%20better%20sleep%20and%20fewer%20pills%20but%20insurance%20say...%20%40drcaplan&url=https%3A//example.com/meme/when-your-75-year-old-patient-has-better-sleep-and-fewer-pills-but-insurance-say)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//example.com/meme/when-your-75-year-old-patient-has-better-sleep-and-fewer-pills-but-insurance-say)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20When%20your%2075-year-old%20patient%20has%20better%20sleep%20and%20fewer%20pills%20but%20insurance%20say...%20--%20via%20%40drcaplan.bsky.social%20https%3A//example.com/meme/when-your-75-year-old-patient-has-better-sleep-and-fewer-pills-but-insurance-say)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://example.com/meme/when-your-75-year-old-patient-has-better-sleep-and-fewer-pills-but-insurance-say](https://example.com/meme/when-your-75-year-old-patient-has-better-sleep-and-fewer-pills-but-insurance-say) Table of Contents - [FAQ](#FAQ)[What benefits of cannabis in older adults does this article describe?](#What_benefits_of_cannabis_in_older_adults_does_this_article_describe) - [Why does lack of insurance coverage matter for seniors using cannabis?](#Why_does_lack_of_insurance_coverage_matter_for_seniors_using_cannabis) - [What often happens when older patients cannot afford to continue cannabis?](#What_often_happens_when_older_patients_cannot_afford_to_continue_cannabis) - [Related](#Related) ## FAQ ### What benefits of cannabis in older adults does this article describe? According to the article, cannabis medicine often leads to improved sleep architecture, reduced benzodiazepine dependence and a decreased overall medication burden in older adults. The piece is an education post for clinicians and caregivers that focuses on how these benefits collide with gaps in insurance coverage. ### Why does lack of insurance coverage matter for seniors using cannabis? The article explains that insurance non-coverage creates a two-tiered system in which clinical efficacy does not translate into accessible care. As a result, many seniors are forced to choose between the [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/) they have experienced and the financial sustainability of continuing treatment. ### What often happens when older patients cannot afford to continue cannabis? The article says this often leads to discontinuation of an effective treatment and a return to less optimal pharmaceutical regimens with higher side effect profiles. In other words, treatment is stopped because of cost rather than because it stopped working. {“@context”:”https://schema.org”,”@type”:”Article”} RELATED READING AT CED CLINIC Continue exploring the evidence [Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know](https://cedclinic.com/tenet-healthcare-revvity-avantor-azenta-and-elanco-shares-plummet-what-you-need-to-know/) Insights into healthcare market fluctuations impacting senior care and insurance coverage policies. [Learn More](https://cedclinic.com/tenet-healthcare-revvity-avantor-azenta-and-elanco-shares-plummet-what-you-need-to-know/) [The Best CBD for Immune Support and Daily Resilience in 2026](https://cedclinic.com/the-best-cbd-for-immune-support-and-daily-resilience-in-2026-stupiddope-est-2008/) Explore CBD options that support overall health and wellness, relevant for seniors managing multiple medications. [Explore CBD Options](https://cedclinic.com/the-best-cbd-for-immune-support-and-daily-resilience-in-2026-stupiddope-est-2008/) 12 Best Alcohol Stocks to Buy Right Now [Market trends](https://cedclinic.com/cannabis-vaporizer-market-trends-harm-reduction/) that may influence healthcare funding and insurance policies affecting senior [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/). View [Market Trends](https://cedclinic.com/cannabis-vaporizer-market-trends-harm-reduction/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).